Author: Greg Winterton

Recent months have delivered two significant developments that could profoundly impact life expectancy for those with chronic kidney disease.

Central Bank of Ireland AIFMD Q&A update delivers benefits to life settlement fund managers.

W L Consulting’s Roger Lawrence offers his views on the UK’s Life Insurance Stress Test.

A new paper from Klarity and Munich Life Re US has examined physical activity data from wearable technology and tied this data to mortality risk.

Aggregate surplus fell from £239.0bn in January to £232.7bn at the end of February.

Universal life insurance applications declined -18.5% versus February last year.

The transaction scope includes blocks of in-force structured settlement annuities and secondary guarantee universal life business

The transaction covers over 850 deferred members and approximately 650 pensioners.

The buy-out transaction was completed in January 2025, with the buy-in having taken place in July 2024.

Finnerty will take up the position on 31st March 2025, succeeding Orla O’Connor, who is completing her six-year term as Chair.